At the 2026 European Hematology Association congress, CARsgen Therapeutics unveiled clinical data for its allogeneic CAR T-cell candidates, CT0596 and CT1190B. The results highlight promising efficacy and safety profiles for patients with relapsed or refractory multiple myeloma and B-cell non-Hodgkin's lymphoma, signaling a potential shift in cell therapy accessibility.
A Delaware jury has ruled that Amgen and its subsidiary Teneobio willfully infringed on a foundational antibody discovery patent held by Harbour BioMed. The verdict, delivered after a brief three-hour deliberation, awards the biopharmaceutical company $20.2 million and validates the integrity of its proprietary transgenic rodent technology.
Bambu Lab has launched its 4th Anniversary Sale, marking the first time the company has applied discounts to its P2S, H2S, and H2C 3D printer models. The month-long event runs from June 15 through July 15, offering reduced pricing across the US, EU, UK, Canada, and Australian markets.
Bambu Lab is marking its fourth anniversary with a global sale running from June 15 through July 15, 2026, offering unprecedented discounts on its 3D printer lineup. The promotion includes the first-ever price reductions for the P2S, H2S, and H2C models across markets in the US, Europe, and beyond.
Consumers are increasingly bypassing mass-produced items in favor of deeply personalized Father’s Day gifts, pushing small businesses and makers toward high-precision laser engraving. This shift highlights a broader retail trend where sentimental value and customization have become the primary drivers for holiday sales performance.
Jason Christie did not believe he was destined for a win until the trophy was in his hands. The Oklahoma pro secured his second victory of the 2026 season at the Maxam Bassmaster Elite Series, finishing with a four-day total of 92 pounds, 7 ounces despite struggling to maintain a consistent pattern.
A class action lawsuit filed in Orange County Superior Court accuses Empyrean Anaheim Resort, Inc. of systemic labor violations, including the denial of mandatory meal and rest periods. The complaint, brought by Blumenthal Nordrehaug Bhowmik De Blouw LLP, alleges the resort manipulated time records to avoid paying legally required penalties.
Investors who purchased Phreesia, Inc. common stock between May 8, 2025, and March 30, 2026, have until July 13, 2026, to apply for lead plaintiff status in a pending class action lawsuit. The litigation targets alleged misrepresentations regarding the company’s slowing demand and weakened pharmaceutical marketing revenue.
Investors who purchased GeneDx Holdings Corp. securities between April 16, 2025, and May 4, 2026, are being alerted to a securities fraud class action lawsuit. The filing follows a massive share price decline triggered by disappointing first-quarter results and a significant impairment charge related to the company’s acquisition of Fabric Genomics.
A new concept study suggests that PMET Resources could bypass traditional offshore refining by processing spodumene concentrate directly at its Shaakichiuwaanaan site in Quebec. By adopting an atmospheric leach process, the company aims to leverage local hydroelectric power to produce battery-grade lithium carbonate while cutting logistics-heavy transport costs.
Investors who purchased Verra Mobility Corporation common stock between February 24 and May 26, 2026, are being sought to join a pending securities class action lawsuit. Rosen Law Firm, representing the plaintiffs, has set an August 4, 2026, deadline for those wishing to serve as lead plaintiff in the litigation.
As physical performance and long-term mobility become central to aging well, Manassas-based PureHealth Research is positioning its latest supplement line to address the intersection of strength training and recovery through a blend of magnesium, ashwagandha, and omega-3 fatty acids.
Investors who held FLOW cryptocurrency between December 27 and December 29, 2025, are being urged to contact the Rosen Law Firm. The firm is currently investigating potential securities claims against the Flow Foundation, alleging the organization disseminated materially misleading business information to the public.
The Orbis Flying Eye Hospital has touched down in Arequipa, Peru, launching a two-week intensive training program for local medical professionals. In collaboration with the Ministry of Health and Hospital Regional Honorio Delgado Espinoza, the mission aims to bolster ophthalmic care across the country’s southern, often underserved, regions.
A 22% plunge in Disc Medicine’s stock price on February 13, 2026, has triggered a formal investigation by Rosen Law Firm. The legal action centers on allegations that the biotech company misled shareholders regarding the viability of its bitopertin drug program, which recently failed to secure FDA approval.
Nearly 90% of confirmed Ebola cases in the Democratic Republic of Congo are concentrated in the Ituri Province, prompting Samaritan's Purse to launch two emergency field hospitals. These facilities in Bunia and Nyankunde aim to isolate patients and provide urgent care as the viral outbreak continues to climb.
At 8:30 a.m. on Monday, June 15, 2026, the team at Tradr ETFs will ring the Opening Bell at Cboe Global Markets. The ceremony marks the debut of the Tradr 2X Long SpaceX Daily ETF (SPCM) and the Tradr 2X Short SpaceX Daily ETF (SPCG), both designed for high-conviction, short-term trading.
The combination of selinexor and ruxolitinib has met a primary endpoint in the Phase 3 SENTRY trial, demonstrating a statistically significant reduction in spleen volume for patients with frontline myelofibrosis. Presented at the EHA 2026 Congress, the results highlight a potential shift in treatment efficacy for this rare blood cancer.
Adding Eli Lilly’s pirtobrutinib to a standard venetoclax and rituximab regimen significantly improved outcomes for patients with relapsed or refractory chronic lymphocytic leukemia, according to results from the Phase 3 BRUIN CLL-322 trial presented ahead of the 2026 European Hematology Association Annual Meeting.
Investors who sustained losses exceeding $100,000 in Zillow Group stock have until August 10, 2026, to file lead plaintiff applications. The class action lawsuit, pending in the Western District of Washington, centers on allegations that the company obscured the true nature of its agreement with Redfin.
Three infants in California, Pennsylvania, and Washington have been hospitalized with botulism, prompting a nationwide recall of Nara Organics Whole Milk Organic Powdered Infant Formula. Health officials identified the product, sold through Target and online, as the source of type A botulinum toxin infections occurring between April and May.
Investors who purchased Babcock & Wilcox Enterprises, Inc. securities between November 5, 2025, and March 11, 2026, have until June 15, 2026, to file as lead plaintiffs in a pending class action lawsuit alleging that the company misled shareholders regarding its financial prospects and contractual relationships.
Investors who purchased POET Technologies Inc. securities between April 1 and April 27, 2026, face a June 29 deadline to petition the court to serve as lead plaintiff in a class action lawsuit alleging securities fraud against the company and its executives.
Employees at Victoria's Secret Stores, LLC are taking the company to court, alleging a systematic failure to provide mandated meal and rest breaks. The class action complaint, filed in Los Angeles County Superior Court, claims the retailer routinely bypassed California labor protections to avoid paying required wages and penalties.
Standing before a crowd of parents and educators outside the San Diego campus on June 12, Margaretta Boutserse launched a wrongful termination suit against Albert Einstein Academies. The veteran principal alleges she was fired after refusing to undermine teacher unionization efforts, a demand she claims violated California law.
A 10.5% drop in TruBridge stock on March 17, 2026, followed the company’s admission that it could not file its annual report due to significant accounting errors. The firm is now the subject of a securities class action investigation led by the Rosen Law Firm, which alleges the company misled shareholders.
Under the glow of the Huangpu River, the 28th Shanghai International Film Festival launched today, marking the start of a week-long celebration of global cinema. The event, one of only 17 FIAPF-accredited competitive festivals worldwide, drew industry luminaries to a city now hosting over 1,600 screenings through June 20.
Investors who purchased Verra Mobility common stock between February 24 and May 26, 2026, are now eligible to join a securities fraud class action. The lawsuit, filed in the U.S. District Court for the District of Arizona, follows a sharp decline in share price triggered by the loss of a major contract.
At the European Society of Human Genetics conference in Gothenburg, MGI Tech is pivoting toward a collaborative model, launching a partner enablement program to integrate its sequencing platforms directly into clinical diagnostic workflows while opening its automation technology to original equipment manufacturers.
With $123 million in total commitments, Kos Biotechnology Partners has finalized the third closing of its inaugural fund, marking the largest venture capital launch in Greek history. The firm, operating out of New York and Athens, aims to bridge the gap between American drug development expertise and European scientific talent.
